Evaluation of Guidelines on Diabetes Medication
Authors: Wendy L. Bennett, Olaide A. Odelola, Lisa M. Wilson
Journal: Annals of Internal Medicine (2012)

Letters15 May 2012Evaluation of Guidelines on Diabetes MedicationWendy L. Bennett, MD, MPH, Olaide A. Odelola, MD, MPH, and Lisa M. Wilson, ScMWendy L. Bennett, MD, MPHFrom The Johns Hopkins University School of Medicine, Baltimore, MD 21205.Search for more papers by this author, Olaide A. Odelola, MD, MPHFrom The Johns Hopkins University School of Medicine, Baltimore, MD 21205.Search for more papers by this author, and Lisa M. Wilson, ScMFrom The Johns Hopkins University School of Medicine, Baltimore, MD 21205.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-156-10-201205150-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We appreciate the letters by Dr. Brown and colleagues and Dr. Giaccari and colleagues. We have also received e-mails from guideline developers concerned about several missed guidelines related to oral medication treatment for type 2 diabetes. In response, our team carefully reviewed our search strategy and did an updated search of the National Guideline Clearinghouse (NGC); we identified guidelines that unfortunately were not captured in our original search.We discussed our concerns with NGC staff members and identified several problems with our broad search (“type 2 diabete*”). Most important, the NGC Web site, including the search function, was ...References1. Scottish Intercollegiate Guidelines Network. Management of Diabetes. A National Clinical Guideline. Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network; 2010. Accessed at www.sign.ac.uk/pdf/sign116.pdf on 11 April 2012. Google Scholar2. Department of Veteran Affairs. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus. 2010. Accessed at www.healthquality.va.gov/diabetes/DM2010_FUL-v4e.pdf on 11 April 2012. Google Scholar3. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17 Suppl 2 1-53. [PMID: 21474420] CrossrefMedlineGoogle Scholar4. Aspray TJ, Yarnall AJ, Croxson SC, Chillala J, Sinclair AJ; British Geriatrics Society. Best Practice Guide: Diabetes. 2009. Accessed at www.bgs.org.uk/Publications/Publication%20Downloads/good_practice_full/Diabetes_6-4.pdf on 11 April 2012. Google Scholar5. Canadian Agency for Drugs and Technologies in Health. Optimal Therapy Recommendations for the Prescribing and Use of Second-Line Therapy for Patients with Diabetes Inadequately Controlled on Metformin. 2010. Accessed at www.cadth.ca/media/pdf/C1110_OT_Reccommendations_final_e.pdf on 11 April 2012. Google Scholar6. Canadian Agency for Drugs and Technologies in Health. CADTH Therapeutic Review Panel Recommendations: Third-Line Therapy for Patients with Type 2 Diabetes Inadequately Controlled with Metformin and a Sulfonylurea. 2010. Accessed at www.cadth.ca/media/pdf/Diabetes_TR_Recommendations_Final_e.pdf on 11 April 2012. Google Scholar7. California Diabetes Program. Basic Guidelines for Diabetes Care. 2009. Accessed at www.caldiabetes.org/content_display.cfm?ContentID=743 on 11 April 2012. Google Scholar8. University of Michigan Health System. Guidelines for Clinical Care: Management of Type 2 Diabetes Mellitus. 2008. Accessed at cme.med.umich.edu/pdf/guideline/dm08.pdf on 11 April 2012. Google Scholar9. Wisconsin Diabetes Prevention and Control Program. Wisconsin Diabetes Mellitus Essential Care Guidelines. 2011. Accessed at www.dhs.wisconsin.gov/publications/P4/P49356.pdf on 11 April 2012. Google Scholar10. Bruno G, De Micheli A, Frontoni S, Monge L; Società Italiana di Diabetologia-Associazione Medici Diabetologi (SID-AMD) Working Group on the Standards of Care for Diabetes. Highlights from “Italian Standards of Care for Diabetes Mellitus 2009-2010”. Nutr Metab Cardiovasc Dis. 2011;21:302-14. [PMID: 20851582] MedlineGoogle Scholar11. Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147:386-99. [PMID: 17638715] LinkGoogle Scholar Author, Article, and Disclosure InformationAuthors: Wendy L. Bennett, MD, MPH; Olaide A. Odelola, MD, MPH; Lisa M. Wilson, ScMAffiliations: From The Johns Hopkins University School of Medicine, Baltimore, MD 21205.Disclosures: None disclosed. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1625. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoEvaluation of Guideline Recommendations on Oral Medications for Type 2 Diabetes Mellitus Wendy L. Bennett , Olaide A. Odelola , Lisa M. Wilson , Shari Bolen , Saranya Selvaraj , Karen A. Robinson , Eric B. Bass , and Milo A. Puhan Evaluation of Guidelines on Diabetes Medication Keith Brown , Robin Harbour , and John Petrie Evaluation of Guidelines on Diabetes Medication Andrea Giaccari , Carlo B. Giorda , Gabriele Riccardi , Alberto De Micheli , Graziella Bruno , Luca Monge , and Simona Frontoni Metrics Cited byType 2 diabetes guidelines: keeping Scotland on the map 15 May 2012Volume 156, Issue 10Page: 753-754KeywordsConflicts of interestDatabasesDiabetes mellitusLibrariesTreatment guidelinesType 2 diabetes ePublished: 15 May 2012 Issue Published: 15 May 2012 Copyright & PermissionsCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...